When machine learning is used to suggest new potential scientific insights or directions, algorithms sometimes offer ...
The rate of HIV infection continues to climb globally. Around 40 million people live with HIV-1, the most common HIV strain.
About one-third of all drugs approved by the Food and Drug Administration target the largest family of cell membrane ...
After walking away from cell therapy and narrowing its focus to just three modalities, Takeda is doubling down on its ...
Bristol Myers Squibb have extended their research collaboration aimed at designing and optimizing small-molecule drugs for ...
Dianthus Therapeutics and Boehringer Ingelheim headlined the latest round of licensing d | Dianthus and Boehringer Ingelheim ...
Expedition Medicines has emerged from stealth with $50 million in funding from Flagship Pioneering. The start-up uses ...
An MIT team used artificial intelligence to design novel antibiotics, two of which showed promise against MRSA and gonorrhea.
U.S. biotech firm Nabla Bio said on Tuesday it has signed a second major research partnership with Japanese drugmaker Takeda ...
News Medical on MSN
Machine learning advances drug discovery through generalizable models
The drug development pipeline is a costly and lengthy process. Identifying high-quality "hit" compounds-those with high potency, selectivity, and favorable metabolic properties-at the earliest stages ...
A researcher has proposed a more targeted approach to AI drug discovery, which includes a rigorous evaluation protocol.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback